---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-026813"
form_type: "8-K"
ticker: null
cik: "0001671818"
company_name: "Oncorus, Inc."
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T05:54:09.726723+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Oncorus board approves dissolution plan, appoints Interim CEO and President

## Summary
- Board approved Plan of Liquidation and Dissolution; special stockholder meeting to seek approval.
- Brian Shea appointed Interim CEO and President; eligible for retention bonus of six months' base salary.
- Ted Ashburn appointed Chairman, replacing Mitchell Finer; director Luke Evnin resigned from board.
- Company warns trading in ONCR stock is highly speculative; stockholders may realize little value.

## SEC filing metadata
- accession: 0000950170-23-026813
- form_type: 8-K
- cik: 0001671818
- company_name: Oncorus, Inc.
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671818/000095017023026813/0000950170-23-026813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671818/000095017023026813/oncr-20230606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-026813
- JSON: https://secwatch.observer/filing/0000950170-23-026813.json
- Plain text: https://secwatch.observer/filing/0000950170-23-026813.txt

## Key facts
- Executive change
  Brian Shea was appointed as Interim Chief Executive Officer and President at Oncorus, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer and President
  source text: the Board appointed Brian Shea, age 35, the Company's General Counsel and Secretary, as the Company's Interim Chief Executive Officer and President.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671818/000095017023026813/0000950170-23-026813-index.htm
- Executive change
  Mitchell Finer changed role as Chairman of the Board at Oncorus, Inc..
  - Action: stepped down
  - Role: Chairman of the Board
  source text: The Company thanks Dr. Finer for his years of service as Chairman and previously as Executive Chairman.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671818/000095017023026813/0000950170-23-026813-index.htm
- Executive change
  Luke Evnin resigned as Director at Oncorus, Inc..
  - Action: resigned
  - Role: Director
  source text: Luke Evnin, Ph.D. notified the Company of his resignation from the Board as well as the Compensation Committee and Nominating and Corporate Governance Committee of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671818/000095017023026813/0000950170-23-026813-index.htm
- Executive change
  Theodore Ashburn was appointed as Chairman of the Board at Oncorus, Inc..
  - Action: appointed
  - Role: Chairman of the Board
  source text: the Board approved the appointment of Theodore (Ted) Ashburn, M.D., Ph.D. as Chairman of the Board, to replace Mitchell Finer, Ph.D.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671818/000095017023026813/0000950170-23-026813-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.